Tolterodine Tartrate Capsule, Extended Release
NDC Package 31722-607-05
Package Information
Tolterodine Tartrate capsules is a medication used to treat an overactive bladder. This formulation utilizes a capsule, extended release delivery system. Marketed by Camber Pharmaceuticals, Inc., this product is identified by NDC 31722-607 and is authorized under FDA application ANDA206419.
Identification & Billing
- RxCUI: 855182 - tolterodine tartrate 2 MG 24HR Extended Release Oral Capsule
- RxCUI: 855182 - 24 HR tolterodine tartrate 2 MG Extended Release Oral Capsule
- RxCUI: 855182 - tolterodine tartrate 2 MG 24 HR Extended Release Oral Capsule
- RxCUI: 855189 - tolterodine tartrate 4 MG 24HR Extended Release Oral Capsule
- RxCUI: 855189 - 24 HR tolterodine tartrate 4 MG Extended Release Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 31722 - Camber Pharmaceuticals, Inc.
- 31722-607 - Tolterodine Tartrate
- 31722-607-05 - 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE
- 31722-607 - Tolterodine Tartrate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (31722-607). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 31722-607-05 identifies a specific commercial package of 500 capsule, extended release in 1 bottle of Tolterodine Tartrate, a human prescription drug labeled by Camber Pharmaceuticals, Inc.. This capsule, extended release is formulated for oral use and contains tolterodine tartrate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Camber Pharmaceuticals, Inc. on June 02, 2017. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to treat an overactive bladder. By relaxing the muscles in the bladder, tolterodine improves your ability to control your urination. It helps to reduce leaking of urine, feelings of needing to urinate right away, and frequent trips to the bathroom. This medication belongs to the class of drugs known as antispasmodics.
How is this Camber Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 31722060705. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.